Paper · 9010219

Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells.

Joy A and 8 others. Oncogene, 1997. Cited by 126 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells. Papers, record 9010219. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9010219

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells.; PubMed
Journal: Oncogene; PubMed
Year: 1997; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/9010219/; PubMed
DOI: https://doi.org/10.1038/sj.onc.1200823; PubMed
The journal: https://conductscience.org/library/journal-index/8711562; PubMed
Citations, by iCite: 126; iCite
Relative citation ratio, by iCite: 2.62; iCite
Revised in PubMed: 2012-06-05; PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Joy A	A
2	Moffett J	J
3	Neary K	K
4	Mordechai E	E
5	Stachowiak EK	E K
6	Coons S	S
7	Rankin-Shapiro J	J
8	Florkiewicz RZ	R Z
9	Stachowiak MK	M K

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Astrocytes	Major topic
Cell Nucleus	Major topic
Fibroblast Growth Factor 2	Major topic
Glioblastoma	Major topic
Cell Communication
Cell Count
Cell Division
Cells, Cultured
Female
Humans
Male
Neuroglia
Receptor Protein-Tyrosine Kinases
Receptor, Fibroblast Growth Factor, Type 2
Receptors, Fibroblast Growth Factor

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
DK-18811	NIDDK NIH HHS	United States	P01DK018811	PubMed and NIH	NIH RePORTER
HL49376-01A1	NHLBI NIH HHS	United States		PubMed	PubMed
			R01HL049376	NIH	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.

PMID	Title	Journal	Year	In Papers	Source
38,807,663	Panoramic RNA expression of fibroblast growth factors in human glioblastoma tissues and the impact on the survival of patients.	Oncol Lett	2024	https://conductscience.org/library/papers/38807663	PubMed
34,822,110	Identification of ITPR1 as a Hub Gene of Group 3 Medulloblastoma and Coregulated Genes with Potential Prognostic Values.	J Mol Neurosci	2022	https://conductscience.org/library/papers/34822110	PubMed
34,451,524	Propagation of CJD Prions in Primary Murine Glia Cells Expressing Human PrPc.	Pathogens	2021	https://conductscience.org/library/papers/34451524	PubMed
34,068,954	Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.	Cells	2021	https://conductscience.org/library/papers/34068954	PubMed
33,609,076	AS602801 sensitizes glioma cells to temozolomide and vincristine by blocking gap junction communication between glioma cells and astrocytes.	J Cell Mol Med	2021	https://conductscience.org/library/papers/33609076	PubMed
32,174,197	FGF2: a novel druggable target for glioblastoma?	Expert Opin Ther Targets	2020	https://conductscience.org/library/papers/32174197	PubMed
30,867,780	MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2.	Oncol Lett	2019	https://conductscience.org/library/papers/30867780	PubMed
29,344,975	Extracellular matrix and traumatic brain injury.	J Neurosci Res	2018	https://conductscience.org/library/papers/29344975	PubMed
28,213,656	Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme.	Cell Mol Neurobiol	2017	https://conductscience.org/library/papers/28213656	PubMed
26,314,253	The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production.	Mol Cell Biochem	2015	https://conductscience.org/library/papers/26314253	PubMed

1 to 10 of 37

See all 37 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
FGF2	2,247	PubTator's text mining	https://conductscience.org/library/genes/2247	NCBI Gene
FGFR2	2,263	PubTator's text mining	https://conductscience.org/library/genes/2263	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9010219

GET https://conductscience.org/api/papers/v1/9010219/cited_by?page=2

API reference For AI assistants